Showing 161 - 180 results of 33,906 for search '(( 5 nm decrease ) OR ((( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 c decrease ))))', query time: 0.67s Refine Results
  1. 161
  2. 162
  3. 163

    Rescue of <i>MBNL</i>1 e5 and <i>MBNL</i>2 e5 and e8 mis-splicing by erythromycin lactobionate treatment at 10 DPI. by Mougina K. Eltahir (12988153)

    Published 2022
    “…Note the decreased inclusion of <i>MBNL</i>1 e5 (+e5) and <i>MBNL</i>2 e5 (+e5) in DM1 hiNeurons treated with 35 or 65 μM erythromycin for 48 h relative to placebo treated cells. …”
  4. 164

    Discovery of Novel Imidazo[4,5‑<i>c</i>]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Inte... by Xuewu Liang (3071676)

    Published 2022
    “…Especially, lead compound <b>8l</b> showed potent inhibitory activities against interferon-stimulated genes (IC<sub>50</sub>: 3.3 nM) and NF-κB pathways (IC<sub>50</sub>: 150.7 nM) and decreased the release of various proinflammatory factors at the nanomolar level, including IL-6, IL-8, IL-1β, TNF-α, IL-12, and IFN-γ. …”
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169
  10. 170

    5-HT inhibits <i>P</i>. <i>berghei</i> infection in mosquitoes. by Li Gao (131516)

    Published 2024
    “…(J) Oocyst numbers in control (Ctrl, <i>n</i> = 62) and mosquitoes orally supplemented with 10 nM (<i>n</i> = 43), 100 nM (<i>n</i> = 47) and 1000 nM (<i>n</i> = 64) 5-HT. …”
  11. 171

    Numbers of all fractures occurring in men, arranged in order of decreasing mean age, and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age. by Camilla Bergh (9904522)

    Published 2020
    “…<p>Numbers of all fractures occurring in men, arranged in order of decreasing mean age, and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age.…”
  12. 172

    Numbers of all fractures occurring in women, arranged in order of decreasing mean age, and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age. by Camilla Bergh (9904522)

    Published 2020
    “…<p>Numbers of all fractures occurring in women, arranged in order of decreasing mean age, and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age.…”
  13. 173
  14. 174
  15. 175

    Quantifications of SEMG1-2 combined with measurements of CpG methylation levels in the Svs2 and Svs3ab promoters. by Ludwig Stenz (779897)

    Published 2019
    “…(D) Western blot quantifications revealing decreased SEMG2 in sperm of C57.D300.F1 (p<0.04) and C57.D300.F3 (p<0.004) compared with C57.CTL.F1. …”
  16. 176

    Strain-dependent alterations of fertility parameters in male offspring exposed in utero to DEHP. by Ludwig Stenz (779897)

    Published 2019
    “…Compared with C57.CTL.F1, AGD, sperm concentration and VCL were decreased in C57.D300.F1 (p <7*10<sup>−5</sup>, p <0.05, p <0.02, respectively), AGD (p < 0.002), testes weight (p <0.008), VAP (p <0.008), VSL (p <0.008) and VCL (p <0.003) were decreased in C57.D300.F2, and VAP (p <1*10<sup>−3</sup>), VSL (p <1*10<sup>−3</sup>) and VSL (p <0.004) were decreased in C57.D300.F3. …”
  17. 177

    Genetic resistance to DEHP-induced transgenerational endocrine disruption by Ludwig Stenz (779897)

    Published 2019
    “…A DEHP-susceptibility allele in C57BL/6J contained five SNPs (rs28279710, rs32977910, rs46648903, rs46677594 and rs48287999) affecting SHP and six genes (<i>Svs2</i>, <i>Svs3b</i>, <i>Svs4</i>, <i>Svs3a</i>, <i>Svs6</i> and <i>Svs5)</i> epigenetically silenced by DEHP. …”
  18. 178

    Fig 5 - by Marian Adan (16641634)

    Published 2024
    Subjects:
  19. 179
  20. 180

    Selective TASK‑1 Inhibitor with a Defined Structure–Activity Relationship Reduces Cancer Cell Proliferation and Viability by Bárbara Arévalo (4053358)

    Published 2022
    “…Chemical structures of selective blockers of TASK channels contain aromatic groups and amide bonds. Using this rationale, we designed and synthesized a series of compounds based on 3-benzamidobenzoic acid. …”